Angle’s JNJ-trumping Liquid Biopsy System Could See Five-fold Jump In Near-Term Sales
Executive Summary
UK-based Angle plc began developing its circulating tumor cell capture system, Parsortix only in 2011, but the company is now moving into the commercialization phase and expecting a sharp sales ramp-up over the next couple of years.